Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome

Citation
Bkg. Eriksson et al., Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome, CLIN INF D, 27(6), 1998, pp. 1428-1436
Citations number
58
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
CLINICAL INFECTIOUS DISEASES
ISSN journal
10584838 → ACNP
Volume
27
Issue
6
Year of publication
1998
Pages
1428 - 1436
Database
ISI
SICI code
1058-4838(199812)27:6<1428:EACAOI>2.0.ZU;2-0
Abstract
In a retrospective study of invasive infections due to group A Streptococcu s (GAS) in Stockholm during 1987 to 1995, the average incidence per 100,000 residents per year was 2.3, varying between 3.7 per 100,000 (in 1988) and 1.3 per 100,000 (in 1993). Incidence was 1.8 in the age group of 0-4 years but otherwise increased by age, from 0.48 in the age group of 5-14 years to 6.1 among those over 65 years of age. A review of 151 invasive episodes oc curring in 1983-1995 showed cyclic increases of infections due to T1M1-sero type strains during 1986-1990 and 1993-1995. The T1M1 serotype accounted fo r 27 (20%) of 135 available GAS strains. Streptococcal toxic shock syndrome (STSS) developed in 19 (13%) of the 151 episodes. The case fatality rate w as 11% overall but 47% among patients with STSS. In a multivariate logistic regression model, STSS was associated with a history of alcohol abuse (odd s ratio [OR], 6.3; P = .004) and infection with a T1M1 strain (OR, 6.7; P = .007). Case fatality was associated with age (OR, 14.5; P = .08), immunosu ppression (OR, 4.7; P = .02), and STSS (OR, 21.5; P < .0001) but not with T 1M1 infection. Hypotension was significantly associated with a fatal outcom e, regardless of whether STSS developed (P < .0001).